Citations

Showing 10 of 108119 citations.

3D Printing for Bio-Synthetic Biliary Stents
Boyer, Christen J., Boktor, Moheb , Samant, Hrishikesh , White, Luke A. , Wang, Yuping , Ballard, David H. , Huebert, Robert C. , Woerner, Jennifer E., Ghali, Ghali E., Alexander, J. Steven , Alexander, J Steven , Huebert, Robert , Ballard, David H

Mayo Clinic

Bioengineering | February 12, 2019 | Volume: 6 | Issue: 1 | Pages: 16

10.3390/bioengineering6010016 | PMID 30744131 Get It

Three-dimensional (3D) printing is an additive manufacturing method that holds great potential in a variety of future patient-specific medical technologies. This project validated a novel crosslinked polyvinyl alcohol (XL-PVA) 3D printed stent infused with collagen, human placental mesenchymal stem cells (PMSCs), and cholangiocytes. The biofabrication method in the present study examined 3D printing and collagen injection molding for rapid prototyping of customized living biliary stents with clinical applications in the setting of malignant and benign bile duct obstructions. XL-PVA stents showed hydrophilic swelling and addition of radiocontrast to the stent matrix improved radiographic opacity. Collagen loaded with PMSCs contracted tightly around hydrophilic stents and dense choloangiocyte coatings were verified through histology and fluorescence microscopy. It is anticipated that design elements used in these stents may enable appropriate stent placement, provide protection of the stent-stem cell matrix against bile constituents, and potentially limit biofilm development. Overall, this approach may allow physicians to create personalized bio-integrating stents for use in biliary procedures and lays a foundation for new patient-specific stent fabrication techniques.
Hypertrophic olivary degeneration mimics relapse in neuromyelitis optica spectrum disorder
Sechi, Elia , Parks, Natalie, Koeller, Kelly K. , Parks, Natalie E, Sechi, Elia , Flanagan, Eoin P.

Mayo Clinic

Neurology | February 12, 2019 | Volume: 92 | Issue: 7 | Pages: 343-344

10.1212/wnl.0000000000006930 | PMID 30745445 Get It

Why we will never work with the tobacco industry
Hays, J. Taylor , Hurt, R. Douglas

Mayo Clinic

Addiction | February 12, 2019 | Volume: 114 | Issue: 5 | Pages: 934-935

10.1111/add.14582 | PMID 30746811 Get It

Autoimmune Encephalitis Secondary to Melanoma
Daneshmand, Ali , Goyal, Gaurav , Ζεκερίδου, Αναστασία , Hocker, Sara E. , Zekeridou, Anastasia, Goyal, Guarav , Markovic, Svetomir N. , Wijdicks, Eelco F. M.

Mayo Clinic

Annals of Internal Medicine | February 11, 2019 | Volume: 170 | Issue: 12 | Pages: 905-906

10.7326/l18-0593 | PMID 30743260 Get It

Response by Reddy and Borlaug to Letters Regarding Article, “A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure With Preserved Ejection Fraction”
Reddy, Yogesh N.V. , Borlaug, Barry A. , Nishimura, Rick , Borlaug, Barry A

Mayo Clinic

Circulation | February 11, 2019 | Volume: 139 | Issue: 7 | Pages: 992-993

10.1161/circulationaha.118.038818 | PMID 30742532 Get It

Prescribing Practices for Patients With Borderline Personality Disorder During Psychiatric Hospitalizations
Romanowicz, Magdalena , Schak, Kathryn M. , Voort, Jennifer L. Vande , Leung, Jonathan G. , Palmer, Brian A. , Vande Voort, Jennifer L., Larrabee, Beth R. , Leung, Jonathan G

Mayo Clinic

Journal of Personality Disorders | February 11, 2019 | Volume: 34 | Issue: 6 | Pages: 736-749

10.1521/pedi_2019_33_405 | PMID 30742548 Get It

This study aimed to understand prescribing practices during acute psychiatric hospitalization in a large cohort of patients (N = 569) with borderline personality disorder (BPD) at a tertiary care psychiatry unit from January 1, 2013, through January 1, 2015. The mean number of hospitalizations per patient was 1.5 (range, 1–7). The odds of being prescribed antidepressants, antipsychotics, mood stabilizers, hypnotics, or anxiolytics were higher at discharge than at admission. The rate of psychotropic prescriptions was also higher at discharge than at admission (incidence rate ratio, 1.9). This pattern was true for the combined psychotropic and nonpsychotropic (“medical”) prescriptions. Further guidelines are needed regarding optimal psychosocial, medical, and psychopharmacological care of patients with BPD during acute psychiatric hospitalizations.
Treatment of Hyperthyroidism Decreases but Does Not Completely Abolish the Increased Risk of Cardiovascular-Related Hospitalization
Genere, Natalia , Stan, Marius N.

Mayo Clinic

Clinical Thyroidology | February 11, 2019 | Volume: 31 | Issue: 2 | Pages: 49-51

10.1089/ct.2019;31.49-51 Get It

Distinct Cancer-Promoting Stromal Gene Expression Depending on Lung Function
Sandri, Brian J. , Masvidal, Laìa , Murie, Carl , Bartish, Margarita , Avdulov, Svetlana, Higgins, LeeAnn, Bergh, Jonas , Griffin, Timothy J. , Bitterman, Peter B. , Wendt, Chris H. , Larsson, Ola , Wendt, Chris H , Larsson, Ola , Higgins, LeeAnn, Markowski, Todd W. , Peterson, Mark, Yang, Ping , Rolny, Charlotte , Limper, Andrew H. , Griffin, Timothy J

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | February 11, 2019 | Volume: 200 | Issue: 3 | Pages: 348-358

10.1164/rccm.201801-0080oc | PMID 30742544 Get It

Abstract Rationale Chronic obstructive pulmonary disease is an independent risk factor for lung cancer, but the underlying molecular mechanisms are unknown. We hypothesized that lung stromal cells activate pathological gene expression programs that support oncogenesis. Objectives To identify molecular mechanisms operating in the lung stroma that support the development of lung cancer. Methods The study included subjects with and without lung cancer across a spectrum of lung-function values. We conducted a multiomics analysis of nonmalignant lung tissue to quantify the transcriptome, translatome, and proteome. Measurements and Main Results Cancer-associated gene expression changes predominantly manifested as alterations in the efficiency of mRNA translation modulating protein levels in the absence of corresponding changes in mRNA levels. The molecular mechanisms that drove these cancer-associated translation programs differed based on lung function. In subjects with normal to mildly impaired lung function, the mammalian target of rapamycin (mTOR) pathway served as an upstream driver, whereas in subjects with severe airflow obstruction, pathways downstream of pathological extracellular matrix emerged. Consistent with a role during cancer initiation, both the mTOR and extracellular matrix gene expression programs paralleled the activation of previously identified procancer secretomes. Furthermore, an in situ examination of lung tissue showed that stromal fibroblasts expressed cancer-associated proteins from two procancer secretomes: one that included IL-6 (in cases of mild or no airflow obstruction), and one that included BMP1 (in cases of severe airflow obstruction). Conclusions Two distinct stromal gene expression programs that promote cancer initiation are activated in patients with lung cancer depending on lung function. Our work has implications both for screening strategies and for personalized approaches to cancer treatment.
Addressing Frequent Issues of Home Enteral Nutrition Patients
Johnson, Teresa W. , Seegmiller, Sara, Epp, Lisa , Mundi, Manpreet S.

Mayo Clinic

Nutrition in Clinical Practice | February 11, 2019 | Volume: 34 | Issue: 2 | Pages: 186-195

10.1002/ncp.10257 | PMID 30741496 Get It

AbstractThe home enteral nutrition (HEN) population is a medically diverse group whose number has increased substantially in recent decades. Although medically stable compared with acute care patients requiring nutrition support, HEN population needs are unique and require a team approach to manage nutrition. Frequently encountered issues by the HEN team include mechanical issues of the tube site, gastrointestinal and metabolic problems, and patient preferences regarding tube weaning, formula selection, and compliance. A thorough search of the published literature on how to manage these issues was conducted using scientific healthcare databases with the following inclusion criteria: English only, last 10 years, and reviews and clinical trials. Where appropriate, references from the retrieved articles were hand‐searched for relevant articles older than 10 years and cited in this review. The purpose of this review is to provide the HEN team with strategies to address the top issues of home enteral feeding.
Familial recurrence risk with varying amount of family history
Schaid, Daniel J. , Thibodeau, Stephen N. , McDonnell, Shannon K.

Mayo Clinic

Genetic Epidemiology | February 11, 2019 | Volume: 43 | Issue: 4 | Pages: 440-448

10.1002/gepi.22193 | PMID 30740785 Get It

AbstractThe familial recurrence risk is the probability a person will have disease, given a reported family history. When family histories are obtained as simple counts of disease among family members, as often obtained in cancer registries or surveys, we propose methods to estimate recurrence risks based on truncated binomial distributions. By this approach, we are able to obtain unbiased estimates of risk for a person with at least k‐affected relatives, where k can be specified to determine how risk varies with k. We also derive robust variances of the recurrence risk estimate, to account for correlations within families, such as those induced by shared genes or shared environment, without explicitly modeling the factors that cause familial correlations. Furthermore, we illustrate how mixture models can be used to account for a sample composed of low‐ and high‐risk families. Using simulations, we illustrate the properties of the proposed methods. Application of our methods to a family history survey of prostate cancer shows that the recurrence risk for prostate cancer increased from 16%, when there was at least one affected relative, to 52%, when there was at least five affected relatives.